A retrospective multicenter cohort study of Efficacy of pre-exposure prophylaxis to prevent SARS-CoV-2 infection after lung transplantation during the omicron era
Latest Information Update: 27 Mar 2023
At a glance
- Drugs Cilgavimab/tixagevimab (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 27 Mar 2023 New trial record
- 16 Mar 2023 Results published in the Infection